Thymic involution and immune reconstitution

Trends in Immunology

Volumn 30, Issue 7, 2009, Pages 366-373

  Lynch, Heather E ^a   Goldberg, Gabrielle L ^b   Chidgey, Ann ^c   Van den Brink, Marcel R M ^b   Boyd, Richard ^c   Sempowski, Gregory D ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; GHRELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GROWTH HORMONE; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; SEX HORMONE;

AGING; CASTRATION; CELL MATURATION; CELL MIGRATION; DRUG MECHANISM; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INVOLUTION; LIFESPAN; MORBIDITY; MORTALITY; MUCOSA INFLAMMATION; NONHUMAN; ORAL MUCOSITIS; PATHOPHYSIOLOGY; REJUVENATION; REVIEW; T LYMPHOCYTE; THYMOCYTE; THYMUS ATROPHY;

AGING; ANIMALS; CYTOKINES; FIBROBLAST GROWTH FACTOR 7; GONADAL STEROID HORMONES; HUMANS; INTERLEUKIN-7; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 67649396090     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.04.003     Document Type: Review

References (82)

1. Steinmann G.G., et al. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand. J. Immunol. 22 (1985) 563-575
2. Hale L.P. Histologic and molecular assessment of human thymus. Ann. Diagn. Pathol. 8 (2004) 50-60
3. Sempowski G.D., et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J. Immunol. 164 (2000) 2180-2187
4. George A.J., and Ritter M.A. Thymic involution with ageing: obsolescence or good housekeeping?. Immunol. Today 17 (1996) 267-272
5. Goronzy J.J., et al. Aging and T-cell diversity. Exp. Gerontol. 42 (2007) 400-406
6. Sempowski G.D., et al. T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol. Immunol. 38 (2002) 841-848
7. Jamieson B.D., et al. Generation of functional thymocytes in the human adult. Immunity 10 (1999) 569-575
8. Gruver A.L., et al. Immunosenescence of ageing. J. Pathol. 211 (2007) 144-156
9. Sempowski G.D., et al. Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy. Eur. J. Immunol. 32 (2002) 3066-3070
10. Douek D.C., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 (1998) 690-695
11. Flores K.G., et al. Analysis of the human thymic perivascular space during aging. J. Clin. Invest. 104 (1999) 1031-1039
12. Avigan D., et al. Vaccination against infectious disease following hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7 (2001) 171-183
13. Meyers J.D., et al. Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis. 153 (1986) 478-488
14. Whimbey E., et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin. Infect. Dis. 22 (1996) 778-782
15. Whimbey E., et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant. 13 (1994) 437-440
16. Koc Y., et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol. Blood Marrow Transplant. 6 (2000) 44-49
17. Schuchter L.M., et al. Herpes zoster infection after autologous bone marrow transplantation. Blood 74 (1989) 1424-1427
18. Parkman R., et al. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol. Blood Marrow Transplant. 12 (2006) 919-927
19. Savani B.N., et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 107 (2006) 1688-1695
20. Joao C., et al. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma. Bone Marrow Transplant. 37 (2006) 865-871
21. Dixit V.D., et al. Ghrelin promotes thymopoiesis during aging. J. Clin. Invest. 117 (2007) 2778-2790
22. Chen B.J., et al. Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. Exp. Hematol. 31 (2003) 953-958
23. Radtke M.L., and Kolesar J.M. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support. J. Oncol. Pharm. Pract. 11 (2005) 121-125
24. Alpdogan O., et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 107 (2006) 2453-2460
25. Min D., et al. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood 109 (2007) 2529-2537
26. Rossi S.W., et al. Keratinocyte growth factor (KGF) enhances postnatal T- cell development via enhancements in proliferation and function of thymic epithelial cells. Blood 109 (2007) 3803-3811
27. Min D., et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99 (2002) 4592-4600
28. Seggewiss R., et al. Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood 110 (2007) 441-449
29. von Freeden-Jeffry U., et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181 (1995) 1519-1526
30. Peschon J.J., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180 (1994) 1955-1960
31. Maki K., et al. Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 7172-7177
32. Puel A., et al. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat. Genet. 20 (1998) 394-397
33. Andrew D., and Aspinall R. Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J. Immunol. 166 (2001) 1524-1530
34. Phillips J.A., et al. IL-7 gene therapy in aging restores early thymopoiesis without reversing involution. J. Immunol. 173 (2004) 4867-4874
35. Fry T.J., and Mackall C.L. Interleukin-7: from bench to clinic. Blood 99 (2002) 3892-3904
36. Fry T.J., et al. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood 97 (2001) 1525-1533
37. Okamoto Y., et al. Effects of exogenous interleukin-7 on human thymus function. Blood 99 (2002) 2851-2858
38. Pido-Lopez J., et al. Molecular quantitation of thymic output in mice and the effect of IL-7. Eur. J. Immunol. 32 (2002) 2827-2836
39. Alpdogan O., et al. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J. Clin. Invest. 112 (2003) 1095-1107
40. Bolotin E., et al. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88 (1996) 1887-1894
41. Abdul-Hai A., et al. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp. Hematol. 24 (1996) 1416-1422
42. Alpdogan O., et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98 (2001) 2256-2265
43. Mackall C.L., et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97 (2001) 1491-1497
44. Sinha M.L., et al. Interleukin 7 worsens graft-versus-host disease. Blood 100 (2002) 2642-2649
45. Gendelman M., et al. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. J. Immunol. 172 (2004) 3328-3336
46. Barr I.G., et al. Dihydrotestosterone and estradiol deplete corticosensitive thymocytes lacking in receptors for these hormones. J. Immunol. 128 (1982) 2825-2828
47. Olsen N.J., et al. Testosterone induces expression of transforming growth factor-beta 1 in the murine thymus. J. Steroid Biochem. Mol. Biol. 45 (1993) 327-332
48. Viselli S.M., et al. Immunochemical and flow cytometric analysis of androgen receptor expression in thymocytes. Mol. Cell. Endocrinol. 109 (1995) 19-26
49. Olsen N.J., et al. Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology 142 (2001) 1278-1283
50. Ritter M.A., and Boyd R.L. Development in the thymus: it takes two to tango. Immunol. Today 14 (1993) 462-469
51. van Ewijk W., et al. Crosstalk in the mouse thymus. Immunol. Today 15 (1994) 214-217
52. Rossi S.W., et al. RANK signals from CD4+3- inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J. Exp. Med. 204 (2007) 1267-1272
53. Greenstein B.D., et al. Regeneration of the thymus in old male rats treated with a stable analogue of LHRH. J. Endocrinol. 112 (1987) 345-350
54. Pritchard K. Endocrinology and hormone therapy in breast cancer: endocrine therapy in premenopausal women. Breast Cancer Res. 7 (2005) 70-76
55. Wang J., et al. Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility. Fertil. Steril. 85 (2006) 1037-1044
56. Dondi D., et al. GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system. Oncol. Rep. 15 (2006) 393-400
57. Marchetti B., et al. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function. Endocrinology 125 (1989) 1025-1036
58. Sutherland J.S., et al. Activation of thymic regeneration in mice and humans following androgen blockade. J. Immunol. 175 (2005) 2741-2753
59. Heng T.S., et al. Effects of castration on thymocyte development in two different models of thymic involution. J. Immunol. 175 (2005) 2982-2993
60. Goldberg G.L., et al. Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantation. Transplantation 80 (2005) 1604-1613
61. Gray D.H., et al. Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood 108 (2006) 3777-3785
62. Gill J., et al. Generation of a complete thymic microenvironment by MTS24(+) thymic epithelial cells. Nat. Immunol. 3 (2002) 635-642
63. Roden A.C., et al. Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation. J. Immunol. 173 (2004) 6098-6108
64. Goldberg G.L., et al. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J. Immunol. 178 (2007) 7473-7484
65. Kincade P.W., et al. Sex hormones as negative regulators of lymphopoiesis. Immunol. Rev. 137 (1994) 119-134
66. Sutherland J.S., et al. Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin. Cancer Res. 14 (2008) 1138-1149
67. Meropol N.J., et al. Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant. J. Clin. Oncol. 21 (2003) 1452-1458
68. Rosenberg S.A., et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J. Immunother. 29 (2006) 313-319
69. Haynes B.F., et al. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu. Rev. Immunol. 18 (2000) 529-560
70. Haynes B.F., and Hale L.P. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components. Immunol. Res. 18 (1998) 61-78
71. Haynes B.F. The role of the thymic microenvironment in promotion of early stages of human T cell maturation. Clin. Res. 34 (1986) 422-431
72. Douek D.C., et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355 (2000) 1875-1881
73. Hudson L.L., et al. Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection. Semin. Immunol. 19 (2007) 297-309
74. Erickson M., et al. Regulation of thymic epithelium by keratinocyte growth factor. Blood 100 (2002) 3269-3278
75. Finch P.W., and Rubin J.S. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv. Cancer Res. 91 (2004) 69-136
76. Rossi S., et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 100 (2002) 682-691
77. Sakata T., et al. Constitutive expression of interleukin-7 mRNA and production of IL-7 by a cloned murine thymic stromal cell line. J. Leukoc. Biol. 48 (1990) 205-212
78. Alpdogan O., and van den Brink M.R. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol. 26 (2005) 56-64
79. Goodwin R.G., et al. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 60 (1990) 941-951
80. von Freeden-Jeffry U., et al. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7 (1997) 147-154
81. Morrissey P.J., et al. Steel factor (c-kit ligand) stimulates the in vitro growth of immature CD3-/CD4-/CD8- thymocytes: synergy with IL-7. Cell. Immunol. 157 (1994) 118-131
82. Varas A., et al. Interleukin-7 influences the development of thymic dendritic cells. Blood 92 (1998) 93-100